# ESTABLISHING THE AUTHORITY OF SUPPLIERS TO SUPPLY, AND CUSTOMERS TO RECEIVE, MEDICINAL PRODUCTS

## Header

|Item          |Details  |
|--------------|---------------| 
|Purpose       |Detailing the procedure for verifying that medicinal products are only received from suppliers authorised to manufacture and/or supply medicinal products. Detailing the procedure for verifying customers purchasing medicinal product and customers to whom product is delivered are appropriately authorised to purchase medicinal products. 
|Department    |Quality |   
|Category     |GDP         |


## REFERENCES AND ASSOCIATED DOCUMENTS

### References

* [Good Distribution Practice (GDP) Guidelines 2013/C343/01][GDP Guidelines]
* [EudraGMDP]
* [Glossary][QEAIC]
* [Quality Risk Management][LBHIY]
* [Change Control][UYNEF]
* [Outsourced Activities][HBQIN]

## Roles

Role     |   Description    |   Who
------   |   --------       |  ----
Responsible Person |  Reviews and approves the checks; ensures annual review | Responsible Person
Requestor   | Requests checks to be done | Anyone
Operator | Collects documents | Anyone
Quality | Performs annual reviews | Quality

## Procedure

### General requirements

#### General Requirements for suppliers

* A new supplier providing activities under the scope of GDP is evaluated by Quality in accordance with [Outsourced Activities][HBQIN].
* Qualifying a new supplier means confirming that the supplier is appropriately authorised to supply the requested products to the markets in question.
  * If the supply of the medicinal product is directly from a manufacturer or packager, they must hold a valid and appropriate Manufacturing and Importation Authorisation (MIA) and GMP certificate.
  * If the product is being received from a wholesaler or distribution centre, they must hold a valid and appropriate WDA and GDP certificate.
* The authorisation/certification is reconfirmed on an annual basis.
* Official EudraGDMP or local health authority databases should be favored.

#### General Requirements for customers & contract wholesaling sites

* Qualifying a new customer means confirming that the customer is appropriately authorised to receive the requested products.
  * Wholesalers customers need to hold valid WDA and GDP certificates
  * Pharmacies need to be registered as such accordign to local requirements
* Orders cannot be shipped without validating the entity and the shipping address against our validation records.
* The authorisation/certification is reconfirmed on an annual basis. 
* Official EudraGDMP or local health authority databases should be favored.

Contract wholesaling sites are checked with the same procedure as for customers.

### Initiating a check

Requestor requests qualifying a supplier by posing a new GitHub Issue with the 'CHECKS' label.

### Conducting the checks

#### Establishing authority of suppliers

* Operator collects from the relevant databases the relevant authorization certificates as outlined above and post them on the opened Issue. 

#### Establishing authority of customers 

* Operator collects from the relevant databases the relevant authorization certificates as outlined above and post them on the opened Issue. 
* When a customer is supplied products via a 4PL wholesale model the checks are performed by the wholesaler as detailed in the Quality Technical Agreement (QTA).

### Approval of the checks

* The RP of the relevant entity reviews and approves the checks by commenting on the Issue, applying the label 'APPROVED'.
* Operator updates the approved customer and supplier list, with the date of approval 
* The Issue is Closed

### Annual Review of Bona Fides

* The RP ensures the licenses are reviewed on an annual basis

## Training

Anyone who performs the tasks as outlined in this procedure must self-train by reading it.


[GMP Guidelines]: https://ec.europa.eu/health/documents/eudralex/vol-4_en]
[GDP Guidelines]: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2013:343:0001:0014:EN:PDF
[EudraGMDP]: http://eudragmdp.ema.europa.eu
[AMXWS]: /procedures/Procedure_GDP_AMXWS_Management_Procedures.md
[XIDEX]: /procedures/Procedure_GDP_XIDEX_Responsible_Person.md
[BWRPX]: /procedures/Procedure_GDP_BWRPX_Documentation_Control.md
[XCEUG]: /procedures/Procedure_GDP_XCEUG_Deviations.md
[UYNEF]: /procedures/Procedure_GDP_UYNEF_Change_control.md
[OZCFN]: /procedures/Procedure_GDP_OZCFN_Management_review_and_monitoring.md
[LBHIY]: /procedures/Procedure_GDP_LBHIY_Quality_Risk_Management.md
[ZWJPR]: /procedures/Procedure_GDP_ZWJPR_Training.md
[VQICE]: /procedures/Procedure_GDP_VQICE_Receipt_of_medicinal_products.md
[AGTXC]: /procedures/Procedure_GDP_AGTXC_Establishing_the_authority_of_suppliers_to_supply_medicinal_products.md
[ZIWKI]: /procedures/Procedure_GDP_ZIWKI_Customer_complaints.md
[VOZWP]: /procedures/Procedure_GDP_VOZWP_Recall_procedure.md
[HBQIN]: /procedures/Procedure_GDP_HBQIN_Outsourced_activities.md
[GMQHI]: /procedures/Procedure_GDP_GMQHI_Self-inspections.md
[VTOMR]: /procedures/Procedure_GDP_VTOMR_Falsified_Medicinal_Products.md
[BMAXZ]: /procedures/Procedure_GDP_BMAXZ_Medicinal_Product_Returns.md
[YUISV]: /procedures/Procedure_GDP_YUISV_CAPA.md
[QEAIC]: /procedures/Document_QEAIC_Glossary.md
[GGNHM]: /procedures/Procedure_GDP_GGNHM_Reporting_of_Adverse_Events.md
